Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000408 | EKC/KEOPS complex | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
Related structures:
AlphaFold database: E9B4Q2
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process | 6 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 116 | 120 | PF00656 | 0.478 |
CLV_PCSK_FUR_1 | 14 | 18 | PF00082 | 0.537 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.266 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.532 |
CLV_PCSK_PC1ET2_1 | 83 | 85 | PF00082 | 0.266 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.292 |
DEG_SPOP_SBC_1 | 7 | 11 | PF00917 | 0.553 |
DOC_MAPK_gen_1 | 22 | 28 | PF00069 | 0.455 |
DOC_PP1_RVXF_1 | 58 | 65 | PF00149 | 0.466 |
DOC_PP2B_LxvP_1 | 32 | 35 | PF13499 | 0.430 |
DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.445 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.597 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.466 |
LIG_14-3-3_CanoR_1 | 47 | 53 | PF00244 | 0.403 |
LIG_Actin_WH2_2 | 71 | 89 | PF00022 | 0.466 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.466 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.420 |
LIG_FHA_2 | 114 | 120 | PF00498 | 0.545 |
LIG_FHA_2 | 56 | 62 | PF00498 | 0.468 |
LIG_LIR_Nem_3 | 43 | 49 | PF02991 | 0.421 |
LIG_PDZ_Class_1 | 120 | 125 | PF00595 | 0.651 |
LIG_SH3_3 | 103 | 109 | PF00018 | 0.555 |
LIG_SUMO_SIM_par_1 | 72 | 77 | PF11976 | 0.448 |
MOD_CK1_1 | 70 | 76 | PF00069 | 0.431 |
MOD_CK1_1 | 8 | 14 | PF00069 | 0.574 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.468 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.489 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.266 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.266 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.516 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.533 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.600 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.514 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.430 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.403 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.455 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.434 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.448 |
MOD_PIKK_1 | 67 | 73 | PF00454 | 0.466 |
MOD_Plk_1 | 24 | 30 | PF00069 | 0.523 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.505 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.519 |
TRG_Pf-PMV_PEXEL_1 | 47 | 52 | PF00026 | 0.230 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZE2 | Leptomonas seymouri | 80% | 100% |
A0A3S7X7K3 | Leishmania donovani | 94% | 100% |
A0A422N8R9 | Trypanosoma rangeli | 38% | 100% |
A4HAJ0 | Leishmania braziliensis | 82% | 100% |
A4IAL9 | Leishmania infantum | 94% | 100% |
Q4Q3C4 | Leishmania major | 97% | 100% |